arrow
L

Laura Biganzoli

azienda usl toscana centro
H指数:64
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study

CDK4/6抑制剂剂量模式在老年转移性乳腺癌患者中的分布:一项跨国调查研究

2026-07-010
PRE
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report

激素受体阳性/HER2阴性转移性乳腺癌的演变格局(EVOLVE):一项意大利Delphi共识报告

2025-06-060
OA
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan

沙芬戈曲普坦治疗转移性三阴性乳腺癌患者不良反应管理的德尔菲共识

2025-05-140
OA
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer

通过体细胞拷贝数异常实现乳腺癌中ctDNA的敏感与精确检测

2025-03-080
OA
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project
2024-12-010
PRE
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial
2024-12-010
PRE
Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients
2024-10-211
OAAI
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

绝经前激素受体阳性早期乳腺癌患者的辅助内分泌治疗选择: 来自前瞻性GIM23-POSTER研究的见解

BREAST
IF7.9
2024-10-011
OAAI
Impact of geriatrician-implemented Interventions on chemotherapy (CT) delivery in vulnerable elderly patients with early or advanced solid tumors: The GIVE trial

老年科医生实施的干预措施对早期或晚期实体瘤易感老年患者化疗(CT)给药的影响:GIVE试验

2024-09-010
PRE
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7)

BREAST
IF7.9
2024-08-0122
OAAI
Sensitive tumor detection, accurate quantification, and ER subtyping using low-pass methylome of liquid biopsy samples from patients (pts) with metastatic breast cancer (mBC)
2024-05-020
PRE
EUSOMA quality indicators for non-metastatic breast cancer: An update
2024-02-017
PRE